Plant-grown animal protein breakthrough has this small cap rocketing

Today’s big movers inside                                                                                                                                                                                                                                                                                                                                                                                                                 April 22, 2024 Plant-grown animal protein breakthrough has this small cap rocketing *sponsored by Interactive Offers Good morning, 360! Don’t forget to join us today for LIVE trading in the [Market Master’s Room](. JW will be live 9-11 and 3-4 EST today, and Jeff Bishop will be LIVE in [Bullseye]( at 11EST. Friends don’t let friends trade alone in this Market! FOCUS LIST🔎 MLEC - Up over 100% in the pre-market after announcing it is the first company to achieve USDA approval for plant-grown animal proteins SPCB- Up over 25% in pre after reporting 51% annual revenue growth and 5 year record EBITDA for full year 2023 NOTE - Up over 10% in pre after announcing launch of StressLens, a novel AI agent that provides new tools to decode the human element in risk, secures multi-billion dollar quantitative asset management firm as first Stresslens customer *sponsored by Interactive Offers Despite the rocky market, we are still seeing incredible opportunities with momentum stocks right now... This includes Tiziana Life Sciences (TLSA). Note that we said TLSA … not TSLA! TLSA is a clinical-stage biopharmaceutical company developing breakthrough therapies for neuroinflammatory and neurodegenerative diseases with high unmet needs. But since you probably did look at the car company first, you’ll notice that stock has lost about 20% over the last week. TLSA (the correct stock below) is the exact opposite right now. This is an absolutely beautiful chart right now. TLSA has managed to breakout 20% higher over the last week, which is impressive considering that we just saw the largest stock market losses in a long time. It could be because the company has been issuing some fantastic news lately — just this morning they [announced tremendous results]( for patients in their clinical study. With an oversold stock like this, it sure doesn’t take much positive news to get things turning in the right direction again! So do your research on the stock, as trading is very risky and nothing is ever guaranteed. Never trade with more than you can afford to lose, and always have a well-thought-out game plan in place. *Sponsored content/paid advertisement. This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. HOTLIST🔥 MLEC - Up over 100% in the pre-market after announcing it is the first company to achieve USDA approval for plant-grown animal proteins Moolec Science SA (MLEC) is a science-based food ingredient company that focuses on developing real animal proteins in plants using molecular farming. In the pre-market this morning, [MLEC announced]( that it is the first company to achieve USDA approval for plant-grown animal proteins. The USDA-APHIS RSR determined that Moolec's genetically engineered soybean, accumulating animal meat protein, is unlikely to pose an increased plant pest risk relative to non-engineered soybeans. Therefore, it is not subject to the APHIS regulation that governs the movement of organisms modified or produced through genetic engineering (as described in 7 CFR part 340). This milestone reinforces MLEC’s B2B go-to-market strategy for Piggy Sooy™ product, an innovative, functional, and nutritious ingredient. By adding a well-known animal meat protein (porcine myoglobin) to the standard soybean proteins, the company expects to provide food manufacturers with a unique ingredient that will have a positive carbon and water footprint. The stock traded up over 100% in the pre-market after the news. The $3.20 area has acted as resistance in the pre-market and will be an important level to watch. Above it the first target to the upside is the pre-market high at $3.31. Beyond that, $3.40, $3.50 and $4 come into play. Below $3.20, targets to the downside are $2.85, $2.45, $2.20, $2, $1.75 and then a gap fill at $1.40. SPCB- Up over 25% in pre after reporting 51% annual revenue growth and 5 year record EBITDA for full year 2023 SuperCom Ltd (SPCB) provides digital identity, Internet of Things and connectivity, and cyber security products and solutions to governments, and private and public organizations worldwide. The company is headquartered in Tel Aviv, Israel. In the pre-market this morning the [company reported]( Q4 and full year earnings. SPCB reported 51% annual revenue growth, with non-GAAP EPS of $0.47 and 5-year-record EBITDA of $4.8 million for full year 2023 FY 2023: 5-year-record Revenue was $$26.6 million with EBITDA growth of 2350% The stock traded up over 25% in the pre-market after the news. The $0.30 area acted as resistance in the pre-market and will be an important level to watch. Above it, the first major target is the pre-market high at $0.3450. Beyond that $0.40, $0.53 and $0.6298 come into play. Below $0.30, targets to the downside are $0.28, $0.26, $0.24 and then a gap fill at $0.22. New to Options Trading? How does trading ONE Stock, Every Day sound? [Dip your toe in with JW and his crew in Market Navigator!]( We know you can do it 💪 NOTE - Up over 10% in pre after announcing launch of StressLens, a novel AI agent that provides new tools to decode the human element in risk, secures multi-billion dollar quantitative asset management firm as first StressLens customer FiscalNote Holdings Inc. (NOTE) operates as a technology company in North America and internationally. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. In the pre-market this morning, the [company announced]( the launch launch of StressLens, a novel AI agent that provides new tools to decode the human element in risk. NOTE also secured a multi-billion dollar quantitative asset management firm as first Stresslens customer. Stresslens equips users with a pioneering, innovative new AI tool to help decode the human element in mission-critical calls, speeches, testimony, and remarks given by policymakers, CEO’s, regulators, and other key global decision makers. The stock traded up over 10% in the pre-market after the news. The pre-market high of $1.28 will be the first major target for bulls. Above it, targets to the upside are $1.40, $1.60 and $1.80. Below $1.28, targets to the downside are $1.18 and then a gap fill at $1.15. MARKET NEWS 📰 MORE Great Trading Resources: [Get instant access to Jeff Bishop's top trading ideas]( [For great training in options basics, start your journey Jeff Williams]( 💡[Get the hottest stock ideas in Bright Ideas]( Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull *PAID ADVERTISEMENT. Raging Bull has currently been paid seventeen thousand five hundred dollars from Interactive Offers who was compensated by a third party not affiliated with the Company for advertising Tiziana Life Sciences Ltd. The third party, Company, or their affiliates may own and likely wish to liquidate shares of the Company at or near the time you receive this advertisement, which has the potential to hurt share prices. This advertisement and other marketing efforts, including alerts, may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Tiziana Life Sciences Ltd, increased trading volume, and possibly an increased share price of Tiziana Life Sciences Ltd’s securities, which may or may not be temporary and decrease once the marketing arrangement has ended. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of the issuance of this advertisement, the owners of Raging Bull do not hold a position in Tiziana Life Sciences Ltd, though they reserve the right to buy or sell shares in the covered company at any time following the dissemination of this communication. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https: // www. Sec. gov/ edgar/searchedgar /companysearch FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America